Apyx Medical (APYX) Invested Capital (2016 - 2025)
Apyx Medical (APYX) has disclosed Invested Capital for 16 consecutive years, with $14.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 71.32% year-over-year to $14.9 million, compared with a TTM value of $14.9 million through Dec 2025, down 71.32%, and an annual FY2025 reading of $14.9 million, down 71.32% over the prior year.
- Invested Capital was $14.9 million for Q4 2025 at Apyx Medical, down from $43.3 million in the prior quarter.
- Across five years, Invested Capital topped out at $64.4 million in Q4 2023 and bottomed at $14.9 million in Q4 2025.
- Average Invested Capital over 5 years is $47.8 million, with a median of $48.3 million recorded in 2024.
- The sharpest move saw Invested Capital soared 69.97% in 2023, then tumbled 71.32% in 2025.
- Year by year, Invested Capital stood at $54.2 million in 2021, then plummeted by 30.06% to $37.9 million in 2022, then skyrocketed by 69.97% to $64.4 million in 2023, then decreased by 19.54% to $51.8 million in 2024, then plummeted by 71.32% to $14.9 million in 2025.
- Business Quant data shows Invested Capital for APYX at $14.9 million in Q4 2025, $43.3 million in Q3 2025, and $45.0 million in Q2 2025.